Free Trial

TRxADE HEALTH (MEDS) Competitors

TRxADE HEALTH logo
$0.89 +0.00 (+0.33%)
As of 09/8/2025

MEDS vs. UGRO, GNLN, CTNT, GWAV, JXG, JXJT, WTER, BIMI, CUEN, and AENTW

Should you be buying TRxADE HEALTH stock or one of its competitors? The main competitors of TRxADE HEALTH include urban-gro (UGRO), Greenlane (GNLN), Cheetah Net Supply Chain Service (CTNT), Greenwave Technology Solutions (GWAV), Aquaron Acquisition (JXG), JX Luxventure (JXJT), Alkaline Water (WTER), BIMI (BIMI), Cuentas (CUEN), and Alliance Entertainment (AENTW). These companies are all part of the "wholesale" industry.

TRxADE HEALTH vs. Its Competitors

TRxADE HEALTH (NASDAQ:MEDS) and urban-gro (NASDAQ:UGRO) are both small-cap wholesale companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, media sentiment, analyst recommendations and institutional ownership.

TRxADE HEALTH has higher earnings, but lower revenue than urban-gro.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TRxADE HEALTH$7.45M0.17-$17.84MN/AN/A
urban-gro$71.54M0.10-$25.44M-$1.12-0.49

TRxADE HEALTH has a beta of 2.32, suggesting that its stock price is 132% more volatile than the S&P 500. Comparatively, urban-gro has a beta of 1.85, suggesting that its stock price is 85% more volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TRxADE HEALTH
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
urban-gro
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
4.00

urban-gro has a net margin of 0.00% compared to TRxADE HEALTH's net margin of -149.81%. urban-gro's return on equity of 0.00% beat TRxADE HEALTH's return on equity.

Company Net Margins Return on Equity Return on Assets
TRxADE HEALTH-149.81% -196.79% -112.21%
urban-gro N/A N/A N/A

5.7% of TRxADE HEALTH shares are held by institutional investors. Comparatively, 20.6% of urban-gro shares are held by institutional investors. 48.4% of TRxADE HEALTH shares are held by company insiders. Comparatively, 26.9% of urban-gro shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, urban-gro had 3 more articles in the media than TRxADE HEALTH. MarketBeat recorded 3 mentions for urban-gro and 0 mentions for TRxADE HEALTH. urban-gro's average media sentiment score of 0.20 beat TRxADE HEALTH's score of 0.00 indicating that urban-gro is being referred to more favorably in the news media.

Company Overall Sentiment
TRxADE HEALTH Neutral
urban-gro Neutral

Summary

urban-gro beats TRxADE HEALTH on 9 of the 13 factors compared between the two stocks.

Get TRxADE HEALTH News Delivered to You Automatically

Sign up to receive the latest news and ratings for MEDS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MEDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MEDS vs. The Competition

MetricTRxADE HEALTHDrugs, proprietaries, & sundries IndustryMedical SectorNASDAQ Exchange
Market Cap$1.25M$1.60M$5.83B$10.00B
Dividend YieldN/AN/A5.28%4.52%
P/E RatioN/AN/A75.6926.29
Price / Sales0.170.08518.33172.80
Price / CashN/AN/A37.2059.76
Price / Book1.981.9811.516.41
Net Income-$17.84M-$20.12M$3.28B$270.56M
7 Day Performance-9.01%-3.00%1.45%3.13%
1 Month Performance-57.66%-19.22%11.30%9.74%
1 Year Performance-86.45%-28.82%59.09%28.17%

TRxADE HEALTH Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MEDS
TRxADE HEALTH
N/A$0.89
+0.3%
N/A-86.2%$1.25M$7.45M0.0050
UGRO
urban-gro
0.6357 of 5 stars
$0.40
-2.5%
N/A-63.0%$5.25M$71.54M0.00100Gap Down
High Trading Volume
GNLN
Greenlane
0.3587 of 5 stars
$3.25
-4.4%
N/A-99.9%$4.71M$13.27M0.00260Short Interest ↓
CTNT
Cheetah Net Supply Chain Service
N/A$1.67
+0.2%
N/A-54.5%$4.46M$460K0.0018Short Interest ↓
High Trading Volume
GWAV
Greenwave Technology Solutions
0.9453 of 5 stars
$6.26
-7.9%
N/A-85.9%$3.89M$33.32M0.0090Gap Down
JXG
Aquaron Acquisition
N/A$1.00
+3.0%
N/AN/A$2.18M$49.84M0.0057Positive News
JXJT
JX Luxventure
N/A$0.97
-4.7%
N/A-43.1%$588K$38.49M0.0057
WTER
Alkaline Water
0.3627 of 5 stars
$0.02
-5.9%
N/A-85.6%$314K$62.39M-0.4040News Coverage
Gap Up
BIMI
BIMI
N/A$0.00
flat
N/A-99.5%$1K$12.63M0.00520
CUEN
Cuentas
0.0125 of 5 stars
$0.00
-66.7%
N/AN/A$1K$1.79M0.005Gap Down
AENTW
Alliance Entertainment
N/A$0.32
+23.0%
N/AN/A$0.00$1.07B0.00847News Coverage
Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:MEDS) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners